- Optimal dose of dexmedetomidine for sedation during spinal anesthesia
-
Ok HG, Baek SH, Baik SW, Kim HK, Shin SW, Kim KH
- KMID: 1424905
- Korean J Anesthesiol.
- 2013 May;64(5):426-431.
- doi: 10.4097/kjae.2013.64.5.426
BACKGROUND: Sedation in spinal anesthesia can reduce patient's anxiety and discomfort. Dexmedetomidine has a sedative, hypnotic, analgesic, and minimal respiratory depression effect. However, use of the dexmedetomidine is associated with... -
- CITED
-
- Close
- SHARE
-
- Close
- Can oliceridine (TRV130), an ideal novel µ receptor G protein pathway selective (µ-GPS) modulator, provide analgesia without opioid-related adverse reactions?
-
Ok HG, Kim SY, Lee SJ, Kim TK, Huh BK, Kim KH
- KMID: 2410828
- Korean J Pain.
- 2018 Apr;31(2):73-79.
- doi: 10.3344/kjp.2018.31.2.73
All drugs have both favorable therapeutic and untoward adverse effects. Conventional opioid analgesics possess both analgesia and adverse reactions, such as nausea, vomiting, and respiratory depression. The opioid ligand binds... -
- CITED
-
- Close
- SHARE
-
- Close
- Extraspinal Percutaneous Osteoplasty for the Treatment of Painful Bony Metastasis
-
Lee JH, Kim SY, Ok HG, Kim TK, Kim KH
- KMID: 2403317
- J Korean Med Sci.
- 2018 Feb;33(8):e61.
- doi: 10.3346/jkms.2018.33.e61
BACKGROUND: Extraspinal percutaneous osteoplasties (POPs) are novel techniques for the treatment of painful bony metastasis, which is often the cause of both persistent and incidental breakthrough pain. This retrospective study... -
- CITED
-
- Close
- SHARE
-
- Close
- Can denosumab be a substitute, competitor, or complement to bisphosphonates?
-
Kim SY, Ok HG, Birkenmaier C, Kim KH
- KMID: 2376043
- Korean J Pain.
- 2017 Apr;30(2):86-92.
- doi: 10.3344/kjp.2017.30.2.86
Osteoblasts, originating from mesenchymal cells, make the receptor activator of the nuclear factor kappa B ligand (RANKL) and osteoprotegerin (OPG) in order to control differentiation of activated osteoclasts, originating from... -
- CITED
-
- Close
- SHARE
-
- Close
